AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 31 min read$XAIR

Lin Yi-Chien purchased $57K of XAIR

Lin Yi-Chien purchased 20,393 shares of Beyond Air, Inc. (XAIR) at an average of $2.78 ($2.69–$2.80) across 3 trades over 2026-09-29 to 2026-10-01.

Original reporting
SEC EDGAR · Lin Yi-Chien
Published Oct 3, 2026, 12:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$XAIR
Bullish
medium confidence
Mentioned
$XAIR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XAIRBullishLow
01

Why it matters

The filing provides the first public record of the insider's purchase, offering a modest bullish cue.

02

Market read

New insider purchase may attract short‑term interest but limited overall market impact.

03

What to watch

Potential upcoming financing rounds or dilution could offset any positive signal.

Relevance 4/10Novelty 4/10Timing: today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$XAIRBullishMedium confidence
Context

Insider 10% owner Lin Yi-Chien bought 20,393 shares for $56,590, raising holdings to 145,393 shares.

Expected impact

likely upward pressure as market prices in insider confidence

Evidence & confidence

The purchase is small relative to market cap but the buyer is a 10% owner, indicating personal confidence.

Market effects

Sector

Minimal impact on the aerospace/urban air mobility sector.

Regional

No significant regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The purchase size is too small to move the stock; may be routine portfolio rebalancing.

Key entities

  • company
    Beyond Air, Inc.

    US-listed maker of electric vertical take‑off and landing aircraft.

  • person
    Lin Yi-Chien

    10% owner of Beyond Air, filing the Form 4.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

XAIR insider trading history →

Related articles

AUG 18
$XAIRMed

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Beyond Air ® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 PMA supplement fo

SEC EDGAR 8-K6 min
AUG 15
$XAIRMed

Beyond Air, Inc. Q1 2027 Earnings Call Summary

Beyond Air, Inc. reported Q1 2027 revenue of $1.8 million, citing long hospital contracting cycles. Management said its sales pipeline doubled and secured a national GPO agreement. It reaffirmed 2026 revenue guidance of $8 million and projected 2027 revenue of $16-$18 million, tied to Gen II LungFit PH FDA timing. A $30 million financing supports Gen II launch.

yahoo.com6 min
AUG 14
$XAIRMed

Beyond Air (XAIR) Q1 2027 Earnings Call Transcript

Beyond Air (XAIR) held a Q1 2027 earnings call. It reported Q ended June 30, 2026 revenue of $1.8 million, flat vs the prior quarter, with gross margin rising to 13% from 9%. The company reaffirmed 2026 revenue guidance of $8 million and 2027 guidance of $16 million to $18 million, pending FDA approval for its Gen II LungFit PH system. It also entered a national GPO deal and announced financing up to $30 million.

yahoo.com6 min
AUG 13
$XAIRMedAI 8/10

Beyond Air Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Beyond Air (NASDAQ: XAIR) reported Q2 2026 revenue of $1.8 million and gross margin of 13%. It reaffirmed 2026 revenue guidance of $8 million and 2027 guidance of $16-$18 million, including second-generation LungFit PH revenue pending FDA approval. The company is awaiting FDA review of a PMA supplement, expects a decision in 2H 2026, and raised up to $30.1 million.

finanznachrichten.de6 min
JUN 27
$XAIRMedAI 8/10

Beyond Air (XAIR) Q4 2026 Earnings Call Transcript

Beyond Air (XAIR) reported fiscal 2026 revenue of $7.7 million (+107%) and Q4 revenue of $1.9 million (+66%). Management cited ~90% customer renewal and expects CY 2026 revenue guidance of $8 million and CY 2027 of $16–$18 million. Gross profit was $0.3 million vs a prior-year loss; net loss was $33.2 million. The company also approved a 1-for-20 reverse stock split and guided on Gen 2 regulatory approval as a key catalyst.

fool.com6 min